Why I’d forget the HSBC share price and go for this big dividend financial firm instead

Why I think HSBC Holdings plc (HSBA) is going nowhere and what I’d buy instead.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The share price of banking and financial services company HSBC Holdings (LSE: HSBA) is sliding again. It doesn’t seem able to get get above 700p and stay there. For long-term investors, the situation must be frustrating.

Back in 2005, I used to believe that the firm’s operations around the world made it a decent play on emerging markets. Its trading in Asia, the Middle East, North Africa and Latin America seemed like an ideal way to ride the prosperity that could develop in those regions over the years. The risk was always balanced, I thought then, allied by the company’s strong presence in the developed economies of Europe and North America.

A drag on investor returns

After holding the stock for a couple of years, I realised it was going nowhere and sold out. The problem as I see it with HSBC Holdings is that banking operations are highly cyclical. That leads to the shares being buffeted around by the ups and downs of the macro-economy and by changing investor sentiment. I don’t believe big banks such as HSBC will ever shoot the lights out with investor returns because progress on earnings always seems to lead to the stock market tempering share-price gains by reducing the valuation.

HSBC’s fat dividend is no consolation either. I could collect it for years only to see all my gains wiped out in capital losses when the share price plunges into the next cyclical down-leg. If that happens, the firm’s profits and the dividend could be toast. With an out-and-out cyclical outfit such as HSBC, I think that whole down-leg scenario is an accident just waiting to happen. So I’d forget all about HSBC now and go for a firm in the wider financial sector, such as Ashmore Group (LSE: ASHM).

Today’s full-year results from the specialist emerging markets asset manager revealed that net revenue increased just over 7% compared to last year. Net cash from operations moved just over 29% higher and diluted earnings per share eased by around 10%. The directors held the total dividend for the year at last year’s level.

A positive outlook

The company saw “broad-based” growth in assets under management (AuM), up 26% year-on-year to $73.9bn, and said in the report that its clients have enjoyed decent returns because of Ashmore’s “consistent active investment approach.” Some 73% of AuM outperformed their benchmarks over one year, 94% over three years and 89% over five years. If the company can keep delivering for its clients like this, I reckon the firm’s future looks bright.

Chief executive Mark Coombs explained in the report that asset prices were “more volatile” in the final quarter of the trading year. But he puts that down to the “nervousness about a small number of emerging countries with particular issues such as Turkey.” He thinks the market extended those concerns “across the broad and highly diverse Emerging Markets universe of more than 70 countries.” 

However, in that situation, he sees opportunity for investors to take advantage of the market “mispricing.”

The outlook remains positive and I think Ashmore’s dividend, running around 4.7%, is attractive. I’d rather take my chances with this firm rather than with HSBC Holdings.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK has recommended HSBC Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »